Abstract 5473: Genomic profiling of chemotherapy-related clonal hematopoiesis in patients with high-grade serous ovarian cancer
Sara Corvigno(Karolinska Institutet), Sanghoon Lee(The University of Texas MD Anderson Cancer Center), Emine Bayraktar(The University of Texas MD Anderson Cancer Center), Xingzhi Song(The University of Texas MD Anderson Cancer Center), Shannon N. Westin(The University of Texas MD Anderson Cancer Center), Mark S. Kim(The University of Texas MD Anderson Cancer Center), Elaine Stur(Universidade Federal do Espírito Santo), Joseph Celestino(The University of Texas MD Anderson Cancer Center), Qingxiu Zhang(The University of Texas MD Anderson Cancer Center), Ency Arboleda Goette(The University of Texas MD Anderson Cancer Center), Kenna M. Shaw(National Institutes of Health), Jianhua Zhang(XinHua Hospital), Mohammad Mohammad(The University of Texas MD Anderson Cancer Center), Anil K. Sood(The University of Texas MD Anderson Cancer Center), Ping Song(The University of Texas MD Anderson Cancer Center), Karen Lu(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Amma Asare(The University of Texas MD Anderson Cancer Center), Jun Yao(The University of Texas MD Anderson Cancer Center)
Cited by 1
Related Papers
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k